Tagged: dementia research
What is preclinical Alzheimer’s disease? Preclinical Alzheimer’s is a newly defined stage of the disease reflecting current evidence that changes in the brain may occur years before symptoms affecting memory, thinking or behavior can...
What if we could diagnose Alzheimer’s before symptoms started? The hope is, future treatments could then target the disease in its earliest stages, before irreversible brain damage or mental decline has occurred. Research on...
Charles DeCarli, MD, is a Professor of Neurology and Director of the UC Davis Alzheimer’s Disease Center. He has a strong interest in behavioral neurology, with specific emphasis on dementing disorders, including degenerative dementias...
Growing research evidence suggests that decreased ability to correctly identify odors is a predictor of cognitive decline and an early clinical feature of Alzheimer’s disease. The potential of using smell and eye tests to...
Among the 5.2 million Americans age 65 or older with Alzheimer’s disease, nearly two-thirds (3.3 million) are women. However, new data presented at the Alzheimer’s Association International Conference 2016 (AAIC 2016) in Toronto last...
Gina Martin was raised in Fremont, CA and has been living in Washington, DC for 20 years. She founded The Bob and Diane Fund in honor of her parents’ memory, and as a tribute...
New data suggests that people whose work requires complex thinking and activities are better able to withstand the onset of Alzheimer’s disease. Results “” reported at the 2016 Alzheimer’s Association International Conference (AAIC) in...
Important health policy and health economic research findings were reported last week at the Alzheimer’s Association International Conference 2016 (AAIC 2016) in Toronto, that shed light on system changes that may lead to potential...